0000899243-20-034283.txt : 20201217 0000899243-20-034283.hdr.sgml : 20201217 20201217160511 ACCESSION NUMBER: 0000899243-20-034283 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201215 FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Angelino Mark D. CENTRAL INDEX KEY: 0001814308 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39319 FILM NUMBER: 201396145 MAIL ADDRESS: STREET 1: GENERATION BIO CO. STREET 2: 301 BINNEY STREET, SUITE 401 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Generation Bio Co. CENTRAL INDEX KEY: 0001733294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 814301281 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-529-5908 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-15 0 0001733294 Generation Bio Co. GBIO 0001814308 Angelino Mark D. C/O GENERATION BIO CO., 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Operating Officer Common Stock 2020-12-15 4 M 0 5301 4.59 A 350938 D Common Stock 2020-12-15 4 S 0 4401 34.87 D 346537 D Common Stock 2020-12-15 4 S 0 900 35.52 D 345637 D Common Stock 169846 I See Footnote Stock Option (right to buy) 4.59 2020-12-15 4 M 0 5301 0.00 D 2028-04-01 Common Stock 5301 118460 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.39 to $35.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.41 to $35.84, inclusive. The securities are directly held by the Mark D. Angelino 2020 Qualified Annuity Trust, or the Trust. Mark D. Angelino is the settlor and trustee of the Trust, and the Trust is for the benefit of Elizabeth I., Emily A., John P., and Matthew R. Angelino. The reporting person may be deemed to beneficially own the shares of common stock owned by the Trust. The option to purchase 123,761 shares was granted on April 2, 2018. The shares underlying the option vest over four years, with 25% of the shares vested on April 2, 2019 and the remaining shares vesting in equal quarterly installments thereafter. /s/ Jennifer Elliott, Attorney-in-Fact 2020-12-17